Cargando…

Mesothelin-Specific Immune Responses and Targeted Immunotherapy for Mesothelin-Expressing Tumors

Detalles Bibliográficos
Autores principales: Einama, Takahiro, Kawamata, Futoshi, Kamachi, Hirofumi, Nishihara, Hiroshi, Homma, Shigenori, Matsuzawa, Fumihiko, Mizukami, Tatsuzo, Konishi, Yuji, Kamiyama, Toshiya, Yamamoto, Junji, Taketomi, Akinobu, Todo, Satoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652283/
https://www.ncbi.nlm.nih.gov/pubmed/28965877
http://dx.doi.org/10.1016/j.ebiom.2017.09.033
_version_ 1783273044390707200
author Einama, Takahiro
Kawamata, Futoshi
Kamachi, Hirofumi
Nishihara, Hiroshi
Homma, Shigenori
Matsuzawa, Fumihiko
Mizukami, Tatsuzo
Konishi, Yuji
Kamiyama, Toshiya
Yamamoto, Junji
Taketomi, Akinobu
Todo, Satoru
author_facet Einama, Takahiro
Kawamata, Futoshi
Kamachi, Hirofumi
Nishihara, Hiroshi
Homma, Shigenori
Matsuzawa, Fumihiko
Mizukami, Tatsuzo
Konishi, Yuji
Kamiyama, Toshiya
Yamamoto, Junji
Taketomi, Akinobu
Todo, Satoru
author_sort Einama, Takahiro
collection PubMed
description
format Online
Article
Text
id pubmed-5652283
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-56522832017-10-25 Mesothelin-Specific Immune Responses and Targeted Immunotherapy for Mesothelin-Expressing Tumors Einama, Takahiro Kawamata, Futoshi Kamachi, Hirofumi Nishihara, Hiroshi Homma, Shigenori Matsuzawa, Fumihiko Mizukami, Tatsuzo Konishi, Yuji Kamiyama, Toshiya Yamamoto, Junji Taketomi, Akinobu Todo, Satoru EBioMedicine Commentary Elsevier 2017-09-25 /pmc/articles/PMC5652283/ /pubmed/28965877 http://dx.doi.org/10.1016/j.ebiom.2017.09.033 Text en © 2017 Published by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Commentary
Einama, Takahiro
Kawamata, Futoshi
Kamachi, Hirofumi
Nishihara, Hiroshi
Homma, Shigenori
Matsuzawa, Fumihiko
Mizukami, Tatsuzo
Konishi, Yuji
Kamiyama, Toshiya
Yamamoto, Junji
Taketomi, Akinobu
Todo, Satoru
Mesothelin-Specific Immune Responses and Targeted Immunotherapy for Mesothelin-Expressing Tumors
title Mesothelin-Specific Immune Responses and Targeted Immunotherapy for Mesothelin-Expressing Tumors
title_full Mesothelin-Specific Immune Responses and Targeted Immunotherapy for Mesothelin-Expressing Tumors
title_fullStr Mesothelin-Specific Immune Responses and Targeted Immunotherapy for Mesothelin-Expressing Tumors
title_full_unstemmed Mesothelin-Specific Immune Responses and Targeted Immunotherapy for Mesothelin-Expressing Tumors
title_short Mesothelin-Specific Immune Responses and Targeted Immunotherapy for Mesothelin-Expressing Tumors
title_sort mesothelin-specific immune responses and targeted immunotherapy for mesothelin-expressing tumors
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652283/
https://www.ncbi.nlm.nih.gov/pubmed/28965877
http://dx.doi.org/10.1016/j.ebiom.2017.09.033
work_keys_str_mv AT einamatakahiro mesothelinspecificimmuneresponsesandtargetedimmunotherapyformesothelinexpressingtumors
AT kawamatafutoshi mesothelinspecificimmuneresponsesandtargetedimmunotherapyformesothelinexpressingtumors
AT kamachihirofumi mesothelinspecificimmuneresponsesandtargetedimmunotherapyformesothelinexpressingtumors
AT nishiharahiroshi mesothelinspecificimmuneresponsesandtargetedimmunotherapyformesothelinexpressingtumors
AT hommashigenori mesothelinspecificimmuneresponsesandtargetedimmunotherapyformesothelinexpressingtumors
AT matsuzawafumihiko mesothelinspecificimmuneresponsesandtargetedimmunotherapyformesothelinexpressingtumors
AT mizukamitatsuzo mesothelinspecificimmuneresponsesandtargetedimmunotherapyformesothelinexpressingtumors
AT konishiyuji mesothelinspecificimmuneresponsesandtargetedimmunotherapyformesothelinexpressingtumors
AT kamiyamatoshiya mesothelinspecificimmuneresponsesandtargetedimmunotherapyformesothelinexpressingtumors
AT yamamotojunji mesothelinspecificimmuneresponsesandtargetedimmunotherapyformesothelinexpressingtumors
AT taketomiakinobu mesothelinspecificimmuneresponsesandtargetedimmunotherapyformesothelinexpressingtumors
AT todosatoru mesothelinspecificimmuneresponsesandtargetedimmunotherapyformesothelinexpressingtumors